TY  - GEN
AU  - Gandara,David R
AU  - Leighl,Natasha
AU  - Delord,Jean-Pierre
AU  - Barlesi,Fabrice
AU  - Bennouna,Jaafar
AU  - Zalcman,Gerald
AU  - Infante,Jeffrey R
AU  - Reckamp,Karen L
AU  - Kelly,Karen
AU  - Shepherd,Frances A
AU  - Mazieres,Julien
AU  - Janku,Filip
AU  - Gardner,Olivia S
AU  - Mookerjee,Bijoyesh
AU  - Wu,Yuehui
AU  - Cox,Donna S
AU  - Schramek,Dan
AU  - Peddareddigari,Vijay
AU  - Liu,Yuan
AU  - D'Amelio,Anthony M
AU  - Blumenschein,George
TI  - A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non-Small Cell Lung Cancer
SN  - 1556-1380
PY  - 2017///1121
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carcinoma, Large Cell
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Carcinoma, Squamous Cell
KW  - Docetaxel
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Pemetrexed
KW  - administration & dosage
KW  - Prognosis
KW  - Pyridones
KW  - Pyrimidinones
KW  - Survival Rate
KW  - Taxoids
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study
UR  - https://doi.org/10.1016/j.jtho.2016.11.2218
ER  -